missing translation for 'onlineSavingsMsg'
Learn More
Learn More
STEMCELL Technologies SU9516
Description
- SU9516 is a specific inhibitor of cyclin-dependent kinases (CDKs) including CDK2, CDK1 and, to a lesser extent, CDK4 with IC50 values of 22, 40, and 200 nM, respectively (Lane et al.) It competitively binds in the ATP binding pocket of CDK2 and CDK1 (Moshinsky et al.) It is highly selective and does not inhibit PKC, p38 MAPK, PDGFR or EGFR (IC50 > 10 μM; Lane et al.)
- Decreases proliferation in human colon carcinoma cell lines RKO and SW480, through inhibition of retinoblastoma protein (Rb) phosphorylation, resulting in increased Rb/E2F, cell-cycle arrest, and subsequent apoptosis (Lane et al.; Yu et al.)
- Induces mitochondrial injury, caspase activation and subsequent apoptosis through downregulated transcription of the antiapoptotic protein MCL-1 in U937, Jurkat, and HL-60 leukemia or lymphoma cell lines (Gao et al.)
- Induces apoptosis, alone or in combination with paclitaxel, in the inflammatory breast cancer cell line SUM149PT (Opyrchal et al.)
Specifications
Specifications
| CAS | 377090-84-1 |
| Quantity | 10 mg |
| Molecular Formula | C13H11N3O2 |
| Purity | ≥98% |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?